Panels

• Pharmaceutical Panel: Navigating a Stormy Legal and Regulatory Environment
• Biotechnology Panel: Follow-on Biologics: Outlook and Impact on the Industry
• Medical Devices Panel: Driving the Adoption of Innovative Medical Device Therapies
• Payor & Provider Panel: Innovation in Cost and Quality: The Next Generation of Health Care in the U.S.
• Entrepreneurship Panel: Government's Impact on New Ventures (NIH, FDA, CMS)
• Finance Panel: Consolidation and Financing in Healthcare: Outlook for an Increasingly Cost-Constrained Environment

Pharmaceutical Panel: Navigating a Stormy Legal and Regulatory Environment

• Seth H.Z. Fischer , Company Group Chairman, North America Pharmaceuticals, Johnson & Johnson
• Juergen Lasowski, Head of Business Development and Strategy, Sanofi-Aventis
• David W. Maris, Managing Director and Senior Research Analyst, Banc of America Securities LLC
• Martin K. Reeves , Vice President and Director, The Boston Consulting Group
• Gino Santini, Senior Vice President of Corporate Strategy and Policy, Eli Lilly and Company

Biotechnology Panel: Follow-on Biologics: Outlook and Impact on the Industry

• Alan L. Crane, Chairman and Chief Executive Officer, Momenta Pharmaceuticals
• Marco A. Cacciuttolo, Ph.D., Vice President, Technical Operations, Medarex, Inc.
• Kathryn R. Doyle, Ph.D., J.D., Partner, Drinker Biddle & Reath
• Marc Kozin, President of North American Practice, L.E.K. Consulting
• Suzanne M. Sensabaugh,Vice President, Regulatory Affairs, Global Biogenerics, Teva Pharmaceutical Industries Ltd.
• Heidi L. Wagner, Esq., Senior Director of Government Affairs, Genentech, Inc.
• Gillian R. Woollett, M.A., D.Phil., Chief Scientist, Engel & Novitt, LLP

Medical Devices Panel: Driving the Adoption of Innovative Medical Device Therapies

• Joe Galatowitsch, Senior Director of Patient Access Acceleration, Medtronic
• Ajay Gupta, Partner, McKinsey & Company
• William C. Kolter, Vice-President of Marketing, Biomet Orthopedics, Inc.
• Jeffrey W. Nelson, President, Cardiovascular Division, Thoratec Corporation
• Joe Ross, Director of Marketing, DePuy Spine
• Richard S. Vogel, Vice President, Cardiac Rhythm Management, Guidant Corporation

Payor & Provider Panel: Innovation in Cost and Quality: The Next Generation of Health Care in the U.S.

• Jennifer Daley, M.D., Senior Vice President, Clinical Quality and Chief Medical Officer, Tenet Healthcare
• Suzanne F. Delbanco, Ph.D., Chief Executive Officer, The Leapfrog Group
• Jack Lord, M.D., Senior Vice President and Chief Innovation Officer, Humana
• Paul D. Mango, Director, McKinsey & Company
• Jack Moore, Chief Marketing Officer, Cancer Treatment Centers of America

Entrepreneurship Panel: Government's Impact on New Ventures (NIH, FDA, CMS)

• Mark Baiada, Founder, Bayada Nurses
• Robert J. Borghese, M.A., J.D., Attorney, Borghese Law Firm and Professor, The Wharton School, The University of Pennsylvania
• David Joseph, Co-Founder, Chairman and Chief Executive Officer, Othera Pharmaceuticals
• Joseph W. Kaufmann, President and Chief Executive Officer, Kensey Nash Corporation
• Stephen Roth, President and Chief Executive Officer, Immune Control Inc.
• Damion E. Wicker, M.D., Partner, Life Science and Healthcare Infrastructure Group, J.P. Morgan Partners

Finance Panel: Consolidation and Financing in Healthcare: Outlook for an Increasingly Cost-Constrained Environment

• Greg Brown, M.D, Partner, Paul Capital Partners
• Richard Evans, Senior Analyst, Bernstein Investment Research and Management
• James D. Forbes, Managing Director, Head of Global Healthcare Group, Merrill Lynch
• W. Patrick McMullan III, Senior Managing Director and Co-Head of Worldwide Health Care Investment Banking, Bear Stearns
• Elgar Peerschke, Leader of North America Healthcare Practice Group, Bain & Company
• L. John Wilkerson, General Partner, Galen Partners

© Copyright 2004 Wharton Healthcare Business Conference